Previously treated cases tested for RR-/MDR-TB in Azerbaijan
Azerbaijan: Previously treated cases tested for RR-/MDR-TB was 94.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Azerbaijan, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Azerbaijan stood at 94.0%.
That represents a change of down 5.1% on the previous year and down 6.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Azerbaijan peaked at 100.0% in 2014 and was at its lowest, 7.0%, in 2011.
That places Azerbaijan 72nd out of 180 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 11.0% | — |
| 2006 | 12.0% | +9.1% |
| 2007 | 8.9% | -25.8% |
| 2010 | 48.0% | +439.3% |
| 2011 | 7.0% | -85.4% |
| 2012 | 44.0% | +528.6% |
| 2013 | 55.0% | +25.0% |
| 2014 | 100.0% | +81.8% |
| 2015 | 70.0% | -30.0% |
| 2016 | 61.0% | -12.9% |
| 2017 | 86.0% | +41.0% |
| 2018 | 97.0% | +12.8% |
| 2019 | 98.0% | +1.0% |
| 2020 | 99.0% | +1.0% |
| 2021 | 100.0% | +1.0% |
| 2022 | 100.0% | +0.0% |
| 2023 | 99.0% | -1.0% |
| 2024 | 94.0% | -5.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.6% | 8.9% | 12.0% | 3 |
| 2010s | 66.6% | 7.0% | 100.0% | 10 |
| 2020s | 98.4% | 94.0% | 100.0% | 5 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Heat deaths vs projected death rates 1,241 (2090)
- Un projection of annual infant deaths 264 (2100)
- Population ages 65 and above, female, annual growth rate 7.29 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0536 units per person (2025)
- Population ages 65 and above, male, annual growth rate 8.09 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0381 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Azerbaijan?
- Previously treated cases tested for rr-/mdr-tb in Azerbaijan was 94.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Azerbaijan?
- The highest recorded value was 100.0% in 2014.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Azerbaijan?
- The lowest recorded value was 7.0% in 2011.
- How does Azerbaijan rank for previously treated cases tested for rr-/mdr-tb?
- Azerbaijan ranks 72nd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Azerbaijan?
- Over the last ten years it is down 6.0%. The long-run trend across the full record is volatile.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).